| Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study M Pollán, B Pérez-Gómez, R Pastor-Barriuso, J Oteo, MA Hernán, ... The Lancet 396 (10250), 535-544, 2020 | 2150 | 2020 |
| High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection A Oliver, R Cantón, P Campo, F Baquero, J Blázquez Science 288 (5469), 1251-1253, 2000 | 1912 | 2000 |
| Epidemiology and treatment of multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa infections JP Horcajada, M Montero, A Oliver, L Sorlí, S Luque, S Gómez-Zorrilla, ... Clinical microbiology reviews 32 (4), 10.1128/cmr. 00031-19, 2019 | 1071 | 2019 |
| ESCMID guideline for the diagnosis and treatment of biofilm infections 2014 N Høiby, T Bjarnsholt, C Moser, GL Bassi, T Coenye, G Donelli, ... Clinical microbiology and infection 21, S1-S25, 2015 | 968 | 2015 |
| The increasing threat of Pseudomonas aeruginosa high-risk clones A Oliver, X Mulet, C López-Causapé, C Juan Drug Resistance Updates 21, 41-59, 2015 | 786 | 2015 |
| Antimicrobial susceptibility testing in biofilm-growing bacteria MD Macia, E Rojo-Molinero, A Oliver Clinical Microbiology and Infection 20 (10), 981-990, 2014 | 685 | 2014 |
| Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 EB Hodcroft, M Zuber, S Nadeau, TG Vaughan, KHD Crawford, ... Nature 595 (7869), 707-712, 2021 | 676 | 2021 |
| Community infections caused by extended-spectrum β-lactamase–producing Escherichia coli J Rodríguez-Baño, JC Alcalá, JM Cisneros, F Grill, A Oliver, JP Horcajada, ... Archives of internal medicine 168 (17), 1897-1902, 2008 | 586 | 2008 |
| Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective … B Gutiérrez-Gutiérrez, E Salamanca, M de Cueto, PR Hsueh, P Viale, ... The Lancet Infectious Diseases 17 (7), 726-734, 2017 | 561 | 2017 |
| Antibiotic treatment of biofilm infections O Ciofu, E Rojo‐Molinero, MD Macià, A Oliver Apmis 125 (4), 304-319, 2017 | 521 | 2017 |
| OXA-24, a Novel Class D β-Lactamase with Carbapenemase Activity in an Acinetobacter baumanniiClinical Strain G Bou, A Oliver, J Martínez-Beltrán Antimicrobial Agents and Chemotherapy 44 (6), 1556-1561, 2000 | 475 | 2000 |
| Community-Onset Bacteremia Due to Extended-Spectrum β-Lactamase-Producing Escherichia coli: Risk Factors and Prognosis J Rodríguez-Baño, E Picón, P Gijón, JR Hernández, M Ruíz, C Peña, ... Clinical infectious diseases 50 (1), 40-48, 2010 | 474 | 2010 |
| Hypermutation Is a Key Factor in Development of Multiple-Antimicrobial Resistance in Pseudomonas aeruginosa Strains Causing Chronic Lung Infections MD Maciá, D Blanquer, B Togores, J Sauleda, JL Pérez, A Oliver Antimicrobial agents and chemotherapy 49 (8), 3382-3386, 2005 | 441 | 2005 |
| Coevolution with viruses drives the evolution of bacterial mutation rates C Pal, MD Maciá, A Oliver, I Schachar, A Buckling Nature 450 (7172), 1079-1081, 2007 | 387 | 2007 |
| β-Lactam resistance response triggered by inactivation of a nonessential penicillin-binding protein B Moya, A Dötsch, C Juan, J Blázquez, L Zamorano, S Haussler, A Oliver PLoS pathogens 5 (3), e1000353, 2009 | 379 | 2009 |
| Pseudomonas aeruginosa epidemic high-risk clones and their association with horizontally-acquired β-lactamases: 2020 update E del Barrio-Tofiño, C López-Causapé, A Oliver International journal of antimicrobial agents 56 (6), 106196, 2020 | 374 | 2020 |
| Programas de optimización de uso de antimicrobianos (PROA) en hospitales españoles: documento de consenso GEIH-SEIMC, SEFH y SEMPSPH J Rodríguez-Baño, JR Pano-Pardo, L Alvarez-Rocha, Á Asensio, E Calbo, ... Enfermedades Infecciosas y Microbiología Clínica 30 (1), 22. e1-22. e23, 2012 | 373 | 2012 |
| Genes Encoding TEM-4, SHV-2, and CTX-M-10 Extended-Spectrum β-Lactamases Are Carried by Multiple Klebsiella pneumoniae Clones in a Single Hospital … TM Coque, A Oliver, JC Pérez-Díaz, F Baquero, R Cantón Antimicrobial agents and chemotherapy 46 (2), 500-510, 2002 | 343 | 2002 |
| Chronic Pseudomonas aeruginosa Infection in Chronic Obstructive Pulmonary Disease L Martínez-Solano, MD Macia, A Fajardo, A Oliver, JL Martinez Clinical infectious diseases 47 (12), 1526-1533, 2008 | 341 | 2008 |
| Characterization of Clinical Isolates ofKlebsiella pneumoniae from 19 Laboratories Using the National Committee for Clinical Laboratory Standards Extended … CD Steward, JK Rasheed, SK Hubert, JW Biddle, PM Raney, ... Journal of clinical microbiology 39 (8), 2864-2872, 2001 | 336 | 2001 |
Carlos Juan Immunology associate professor (UIB), Microbiology Researcher Hospital Son Espases, PalmaVerified email at uib.cat
